Why the study?
Does Mokuboito reduce BNP and improve symptoms in patients with severe intractable heart failure?
Does Mokuboito reduce BNP and improve symptoms in patients with severe intractable heart failure?
Mokuboito may be a useful adjunctive treatment for reducing BNP and improving symptoms in patients with severe intractable heart failure who have exhausted standard western medical therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ezaki et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: